about
Downregulation of HTPAP transcript variant 1 correlates with tumor metastasis and poor survival in patients with hepatocellular carcinomaCT Appearance of Hepatocellular Carcinoma after Locoregional Treatments: A Comprehensive ReviewNoninvasive Diagnosis of Hepatocellular Carcinoma: Elaboration on Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guidelines Compared with Other Guidelines and Remaining IssuesGrey zone in the Barcelona Clinic Liver Cancer Classification for hepatocellular carcinoma: Surgeons' perspectiveTransplant benefit for patients with hepatocellular carcinomaDiabetes mellitus and poorer prognosis in hepatocellular carcinoma: a systematic review and meta-analysisTargeted therapy for hepatocellular carcinoma: novel agents on the horizonGuide for diagnosis and treatment of hepatocellular carcinomaA human anti-c-Met Fab fragment conjugated with doxorubicin as targeted chemotherapy for hepatocellular carcinomaResection for hepatocellular carcinoma: is it justifiable to restrict this to the American Association for the Study of the Liver/Barcelona Clinic for Liver Cancer criteria?Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today?Diffusion-weighted imaging of the liver: techniques and applications.Gene expression in nontumoral liver tissue and recurrence-free survival in hepatitis C virus-positive hepatocellular carcinomaGlypican-3-targeted 89Zr PET imaging of hepatocellular carcinoma.Comparative analysis of promoter methylation and gene expression endpoints between tumorous and non-tumorous tissues from HCV-positive patients with hepatocellular carcinoma.Overexpression of Chemokine (C-X-C) ligand 1 (CXCL1) associated with tumor progression and poor prognosis in hepatocellular carcinoma.Association between murine double minute 2 T309G polymorphism and risk of liver cancer.MicroRNA-29a-5p is a novel predictor for early recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection.Laparoscopic ablation of hepatocellular carcinoma in cirrhotic patients unsuitable for liver resection or percutaneous treatment: a cohort studyGlypican-3 targeting of liver cancer cells using multifunctional nanoparticlesGadoxetic acid disodium-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: a meta-analysisElevated expression levels of androgen receptors and matrix metalloproteinase-2 and -9 in 30 cases of hepatocellular carcinoma compared with adjacent tissues as predictors of cancer invasion and stagingSpontaneous complete necrosis of hepatocellular carcinoma: A case report and review of the literatureHepatoprotective versus oncogenic functions of STAT3 in liver tumorigenesis.Imaging of hepatocellular carcinoma patient-derived xenografts using ⁸⁹Zr-labeled anti-glypican-3 monoclonal antibody.SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activationTreatment of hepatocellular carcinoma in the community: disparities in standard therapy.Hepatocellular carcinoma: From diagnosis to treatment.Use of Ethanol in the Trans-Arterial Lipiodol Embolization (TAELE) of Intermediated-Stage HCC: Is This Safer than Conventional Trans-Arterial Chemo-Embolization (c-TACE)?Co-expression patterns of Notch1, Snail, and p53 in grade III hepatocellular carcinoma with postoperative recurrence: a preliminary study.N-Aryl benzenesulfonamide inhibitors of [3H]-thymidine incorporation and β-catenin signaling in human hepatocyte-derived Huh-7 carcinoma cells.Sorafenib for hepatocellular carcinoma patients beyond Milan criteria after orthotopic liver transplantation: a case control studyChemoembolization alone vs combined chemoembolization and hepatic arterial infusion chemotherapy in inoperable hepatocellular carcinoma patientsImpact of oral anti-hepatitis B therapy on the survival of patients with hepatocellular carcinoma initially treated with chemoembolization.Electric Ablation with Irreversible Electroporation (IRE) in Vital Hepatic Structures and Follow-up InvestigationTransarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trialDovitinib preferentially targets endothelial cells rather than cancer cells for the inhibition of hepatocellular carcinoma growth and metastasis.Octreotide and celecoxib synergistically encapsulate VX2 hepatic allografts following transcatheter arterial embolisationGene-expression signature of vascular invasion in hepatocellular carcinoma.A Preoperative Measurement of Serum MicroRNA-125b May Predict the Presence of Microvascular Invasion in Hepatocellular Carcinomas Patients.
P2860
Q24336278-BB4391BC-3357-4F25-9ADA-445CF0405BCDQ26770014-1A14C291-9C8B-425B-BF86-BEE6BB85C60AQ26770020-3D14055D-6453-4304-BF5E-D5A31B772A0DQ26799052-E307EDC9-3EBF-4897-B21C-644BD11B6D54Q26861543-8ABEEE85-D19D-4080-B41B-D83961E3F022Q26864963-7ADB01A3-24D4-444F-AC51-C933AD76990AQ27002288-B8D373EA-E610-4BB2-BCF8-1E29D87F0E13Q28084003-240A2F96-BD3C-4EC9-9F4A-E09B2940FB72Q28487973-694550C3-F463-4215-8253-7CA3A1707DB7Q30410247-6F54DBD2-8521-4757-A799-739D58B70FB6Q30468280-A3993DC1-8D82-4753-89CE-CE2EA5DF31D7Q30840354-A32C08EE-88E1-4952-8CCD-8A8B4202940AQ33797504-33890B25-08C6-4BFA-A0EF-CBFC4467C11BQ33974776-F6789A0B-35D0-473D-BAFE-CBB73AFB8D40Q34168643-2B4D4EDA-C767-447F-B527-F0677C796EE6Q34304058-A4F11CE3-A1A8-469C-B4F0-F3CACFD37705Q34433411-94E06341-6F47-48AA-9D17-B608D8C5364FQ34533796-816FAA8D-314B-4AF7-9169-195BA62C6ED0Q34600274-C103E546-D15E-4E22-AFA0-4C7BF4621E87Q34675546-C10759B3-AEF5-41C4-946D-1CD4F68229D9Q34963150-DE32ADF0-6106-45E9-B4FA-7200D9EC9698Q35048503-8A76C5D6-E6B9-438B-9EE0-4AF6F787DA6CQ35167813-AB489630-F5CF-41B0-906F-EEEF3FE23600Q35167959-38F2A09A-CBE2-4477-B444-A3FBD7A5324BQ35187951-E4ABE440-2D06-4CC2-874E-2F58FB663ABBQ35531218-AF38176F-91AC-45FD-8988-30A17BFD7A1AQ35631429-BCB5BDD8-5FDB-4111-B25E-2244F465B570Q35668716-A08F4C88-4F6C-4EBC-96BD-5213993BF66AQ35674315-E0D86E47-4D5B-4ADE-A54B-A807E82BE3A7Q35890588-A7A0C268-11F7-47DF-99EA-E8F15324F337Q35967478-AC6C4147-A0FD-4A05-8F27-8ACDF46D2506Q35984385-7B05D1D5-2391-411B-B468-6C2CD04CB373Q36085606-5416C858-E283-4175-9DAD-74BDB8F5BB56Q36121202-58258BC6-85AA-4101-829F-7677829310B0Q36262560-963F97FE-CC72-48F5-9ABD-98137632CA91Q36383875-5E261B12-E070-4B0E-8E77-1CFCA06E225BQ36555872-035EAA0E-DE39-4A20-87F0-172671ED9474Q36603626-D6E7770F-5B34-40F6-BBC5-7D60EF0EE993Q36759564-C103927D-589A-4C33-95A6-95DC90F3EECEQ36870217-268F48A6-1D2E-4780-B031-B1A267AEF232
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Major achievements in hepatocellular carcinoma.
@en
Major achievements in hepatocellular carcinoma.
@nl
type
label
Major achievements in hepatocellular carcinoma.
@en
Major achievements in hepatocellular carcinoma.
@nl
prefLabel
Major achievements in hepatocellular carcinoma.
@en
Major achievements in hepatocellular carcinoma.
@nl
P1433
P1476
Major achievements in hepatocellular carcinoma.
@en
P304
P356
10.1016/S0140-6736(09)60381-0
P407
P577
2009-02-01T00:00:00Z